T. Naftali

Papers (1)

• 2005
  The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study.10.1016/J.CLNU.2005.06.001